ID   ME361
AC   CVCL_J760
SY   ME 361; 36.1
DR   ATCC; HB-9325
DR   Wikidata; Q54904963
RX   Patent=US4849509;
RX   PubMed=2918552;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9325.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI:89637; Ganglioside GD2.
CC   Monoclonal antibody target: ChEBI; CHEBI:89636; Ganglioside GD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
RX   Patent=US4849509;
RA   Thurin J., Koprowski H., Herlyn M., Steplewski Z.;
RT   "Monoclonal antibodies against melanoma-associated antigens and hybrid
RT   cell lines producing these antibodies.";
RL   Patent number US4849509, 18-Jul-1989.
//
RX   PubMed=2918552; DOI=10.1093/jnci/81.6.440;
RA   Iliopoulos D., Ernst C.S., Steplewski Z., Jambrosic J.A., Rodeck U.,
RA   Herlyn M., Clark W.H. Jr., Koprowski H., Herlyn D.;
RT   "Inhibition of metastases of a human melanoma xenograft by monoclonal
RT   antibody to the GD2/GD3 gangliosides.";
RL   J. Natl. Cancer Inst. 81:440-444(1989).
//